erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
"we have to thank the coroner and his office for the work they have done. they have clearly listened to all of the evidence and came to the conclusion the family had all along..